follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Edge Therapeutics raises $18M million for drug development

By

Back to Top Comments Email Print

Latest News

advertisement

Edge Therapeutics Inc., a clinical-stage biopharmaceutical company in New Providence, announced today it has raised $18 million in a Series C financing.

Edge said in the announcement it plans to use the proceeds to fund a Phase 2 study of its lead drug candidate, a treatment for the prevention of delayed cerebral ischemia. According to the announcement, Maxim Group LLC was the sole placement agent and financial adviser for the offering.

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top